Possible involvement of endogenous opioids in beta-cell hyperresponsiveness in human obesity.
Since increased opiate production in obesity has been reported, the effects of naloxone in obese subjects were studied in order to ascertain whether endogenous opioid peptides play a role in the abundant insulin secretion of obesity. The results obtained showed that intravenous administration of naloxone considerably reduced insulin of obese subjects to a mixed meal, whereas it did not modify the blood insulin response to arginine or glucose infusion. Glucagon secretion to ingestion of a mixed meal and to arginine infusion was not modified by the opioid receptor blocking agent. This study seems to indicate that hyperproduction of endogenous opioid peptides in obesity increases insulin secretion stimulated by food intake, whereas it does not appreciably affect insulin production stimulated by circulating glucose or aminoacids.
Vettor
R
R
Institute of Semeiotica Medica, University of Padua, Italy.
Martini
C
C
Cestaro
S
S
Manno
M
M
Sicolo
N
N
Federspil
G
G
D000293:Adolescent; D000328:Adult; D004723:Endorphins / Q000378:metabolism*; D005260:Female; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000494:pharmacology*; D009765:Obesity / Q000503:physiopathology*; D001615:beta-Endorphin / Q000378:metabolism*
D004723:Endorphins; D007328:Insulin; D009270:Naloxone; D001615:beta-Endorphin